trending Market Intelligence /marketintelligence/en/news-insights/trending/3d28iss97l4wse9hkrwr5q2 content esgSubNav
In This List

Agenus closes $40M offering of convertible preferred shares

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Agenus closes $40M offering of convertible preferred shares

Agenus Inc. closed an offering of 18,459 convertible preferred shares to certain institutional investors at $2,167 apiece to raise about $40 million in gross proceeds.

Holders can convert each share into 1,000 common stocks at an initial conversion price of $2.167 per common share.

The Lexington, Mass.-based company expects to use the amounts raised for working capital purposes.

Agenus focuses on the development of cancer treatments that engage the body's immune system to fight disease.